Onxeo offre 10,7% de son capital à Invus - Biotech Finances

(French only)

Regards croisés : Interviews of Judith Greciet, CEO of Onxeo, and Mr Nicolas Trebouta, representing Financière de la Montagne, the Company's historical shareholder.